<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01028573</url>
  </required_header>
  <id_info>
    <org_study_id>976</org_study_id>
    <nct_id>NCT01028573</nct_id>
  </id_info>
  <brief_title>A Study Comparing PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to Colonoscopy</brief_title>
  <official_title>A Randomized, Controlled, Single-Blind Study Comparing the Efficacy, Tolerability and Safety of PEG-3350 (Miralax) and Gatorade With PEG-ELS (Golytely) for Bowel Preparation Prior to Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern California Institute for Research and Education</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern California Institute for Research and Education</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study to to see how well Miralax (PEG-3350) and Gatorade cleans the colon
      before a colonoscopy and how easy it is to take compared to Golytely (PEG-ELS) bowel
      preparation solution. Another purpose is to see if taking half of the bowel preparation
      solution on the evening before the colonoscopy and half on the morning of the colonoscopy
      will result in a cleaner colon than taking all of the bowel preparation solution on the
      evening before.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of bowel prepreparation/cleanliness scored using the Boston Bowel Preparation Scale</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Bowel Preparation for Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4L of PEG-ELS (Golytely) consumed on the evening before colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2L of PEG-ELS (Golytely) consumed on the evening before and 2L consumed on the morning of colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>238g of PEG-3350 mixed with 2L of Gatorade</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1L of PEG-3350 + Gatorade</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PEG-ELS (Golytely)</intervention_name>
    <description>4L consumed evening before colonoscopy</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PEG-ELS (Golytely)</intervention_name>
    <description>2L consumed on the evening before and 2L consumed on the morning of Colonoscopy</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Miralax mixed with Gatorade</intervention_name>
    <description>238g of PEG-3350 (Miralax) mixed with 2L of Gatorade consumed on the evening before colonoscopy</description>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Miralax</intervention_name>
    <description>1L of PEG-3350 + Gatorade consumed on the evening before and 1L of PEG-3350 + Gatorade consumed on the morning of Colonoscopy</description>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-80 years in age

          -  Undergoing full colonoscopy for colorectal cancer screening or colon polyp/cancer
             surveillance or other diagnostic purpose

        Exclusion Criteria:

          -  Allergic to polyethylene glycol

          -  Pregnant or lactating

          -  Baseline abnormalities of relevant serum electrolytes including Sodium, Potassium,
             Calcium, Magnesium and phosphorus

          -  Congestive Heart Failure NY Heart Assn, Grades III and IV

          -  Liver Cirrhosis Childs Pugh Class B or C

          -  Serum Creatinine greater than 1.5

          -  Previous alimentary tract surgery

          -  Ongoing symptoms of abdominal pain, bloating, nausea or constipation

          -  Ileus, suspected bowel obstruction, toxic colitis or megacolon, severe ulcerative
             colitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mazen Jamal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Long Beach Healthcare System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mazen Jamal, MD</last_name>
    <phone>(562) 826-5628</phone>
    <email>mazen.jamal@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lea Liu</last_name>
    <phone>(562) 826-5058</phone>
    <email>lea.liu@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VA Long Beach Healthcare System</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822-5201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mazen Jamal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2009</study_first_submitted>
  <study_first_submitted_qc>December 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2009</study_first_posted>
  <last_update_submitted>March 12, 2012</last_update_submitted>
  <last_update_submitted_qc>March 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2012</last_update_posted>
  <responsible_party>
    <name_title>M. Mazen Jamal, MD</name_title>
    <organization>VA Long Beach Healthcare System</organization>
  </responsible_party>
  <keyword>bowel preparation</keyword>
  <keyword>colonoscopy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyethylene glycol 3350</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

